|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/31/20 Acorda Therapeutics Inc. 8-K:8,9 8/31/20 11:165K ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 28K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 12K 7: R1 Document and Entity Information HTML 46K 9: XML IDEA XML File -- Filing Summary XML 12K 6: XML XBRL Instance -- acor-8k_20200831_htm XML 14K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- acor-20200831_lab XML 56K 5: EX-101.PRE XBRL Presentations -- acor-20200831_pre XML 34K 3: EX-101.SCH XBRL Schema -- acor-20200831 XSD 18K 10: JSON XBRL Instance as JSON Data -- MetaLinks 12± 19K 11: ZIP XBRL Zipped Folder -- 0001564590-20-042021-xbrl Zip 11K
EXHIBIT 3.1
CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
ACORDA THERAPEUTICS, INC.
Pursuant to Section 242 of the
General Corporation Law of the State of Delaware
Acorda Therapeutics, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify as follows:
A resolution was duly adopted by the Board of Directors of the Corporation on June 25, 2020 pursuant to Section 242 of the General Corporation Law of the State of Delaware setting forth an amendment to the Amended and Restated Certificate of Incorporation of the Corporation filed with the Delaware Secretary of State on February 15, 2006 (the “Certificate of Incorporation”) and declaring said amendment to be advisable. On August 28, 2020, the stockholders of the Corporation duly approved said proposed amendment at the Corporation’s Special Meeting of Stockholders in accordance with Section 242 of the General Corporation Law of the State of Delaware. The resolution setting forth the amendment is as follows:
|
RESOLVED: |
That the first sentence of Article FOURTH of the Certificate of Incorporation be and hereby is deleted in its entirety and the following sentence is inserted in lieu thereof: |
|
“The Corporation shall have the authority to issue a total of 390,000,000 shares, divided into classes of (i) 370,000,000 shares of Common Stock, $0.001 par value per share (the “Common Stock”), and (ii) 20,000,000 shares of Preferred Stock, $0.001 par value per share (the “Preferred Stock”).” |
IN WITNESS WHEREOF, the Corporation has caused its corporate seal to be affixed hereto and this Certificate of Amendment to be signed by a duly authorized officer of the Corporation this 31st day of August, 2020.
ACORDA THERAPEUTICS, INC.
By: /s/ Andrew Mayer
Name: Andrew Mayer
Title: Deputy General Counsel and
Corporate Secretary
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 8/31/20 | |||
| 8/28/20 | 8-K | |||
| 6/25/20 | ||||
| 2/15/06 | 4 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/23 Acorda Therapeutics, Inc. 10-K 12/31/22 113:19M Donnelley … Solutions/FA 8/16/22 Acorda Therapeutics, Inc. S-8 8/16/22 5:161K Donnelley … Solutions/FA 3/18/22 Acorda Therapeutics, Inc. 10-K 12/31/21 117:16M ActiveDisclosure/FA 3/16/21 Acorda Therapeutics, Inc. 10-K 12/31/20 115:19M ActiveDisclosure/FA 1/13/21 Acorda Therapeutics, Inc. 424B5 1:538K Donnelley … Solutions/FA 11/06/20 Acorda Therapeutics, Inc. 10-Q 9/30/20 75:9.9M ActiveDisclosure/FA 9/17/20 Acorda Therapeutics, Inc. 424B4 1:218K ActiveDisclosure/FA 9/11/20 Acorda Therapeutics, Inc. S-3 3:366K ActiveDisclosure/FA 9/11/20 Acorda Therapeutics, Inc. S-3 5:921K Donnelley … Solutions/FA |